Exicure
Signal active
Investment Firm
Overview
Exicure is Formerly Known as AuraSense Therapeuticsis. Exicure is developing a new class of immunomodulatory and gene silencing drugs against validated targets. Our 3-dimensional, spherical nucleic acid (SNA™) architecture unlocks the potential of nucleic acid therapeutics in multiple organs. Our lead programs address diseases from inflammatory disorders to oncology.
SNA constructs overcome one of the most difficult obstacles to nucleic acid therapeutics: safe and effective delivery into cells and tissues. SNA constructs exhibit unparalleled transfection efficiency into numerous cell and tissue types including the skin without carriers or transfection agents. Moreover, SNAs can be used as potent immunotherapeutic agents for the treatment of cancer or infectious disease.
Highlights
Founded
2009
Industry
Biotechnology
Employees
1-10
Investment
1
Lead Investment
1
Exits
1
Stages
N/A
Investor Type
N/A
Location
United States, North America
Contact Information
Social
Profile Resume
Exicure, established in 2009 and headquartered in United States, North America., specializes in investments across Information Technology, Media and Entertainment, Food Processing. The organization boasts a portfolio of 1 investments, with an average round size of $1.0M and 1 successful exits. Their recent investments include Cyworld. The highest investment round they participated in was $12.0M. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Investment portfolio
Exicure has made 1 investments. Their most recent investment was on May 04, 2023, when Cyworld raised $1.0M.
investments
1
Diversity investments
0
Lead investments
1
Number of exits
1
Investments
1
| Annouced Date | Organization Name | Industry | Money Raised |
|---|---|---|---|
| May 04, 2023 | Cyworld | Information Technology | 1.0M |
CyworldExits
1
Funding Timeline
Funding rounds
1
Investors
26
Funds
0
Funding Rounds
1
Exicure has raised 1 rounds. Their latest funding was raised on May 04, 2023 from a Debt Financing - Cyworld round.
| Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
|---|---|---|---|---|
| May 04, 2023 | Debt Financing - Cyworld | - | 1.0M | - |
Investors
21
Exicure is funded by 21 investor(s). CBI USA and Hercules Capital Kantor are the most recent investors.
| Investor Name | Lead Investor | Funding Round | Money Raised |
|---|---|---|---|
| - | No | Venture Round - Exicure | 11.2M |
| - | No | Venture Round - Exicure | 22.0M |
| - | No | Post-IPO Equity - Exicure | 11.5M |
CBI USA | Yes | Post-IPO Equity - Exicure | 5.4M |
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
| Annouced Date | Fund Name | Money Raised |
|---|---|---|
| May 10, 2013 | OTPPLESS | 1.0M |
| May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
There is no recent news or activity for this profile.